EUVIMEDEUVIMED entdecken
Multizentrische Studie

Real-World Data From India on Delays and Disruptions in Cervical Cancer Care Services During the COVID-19 Pandemic

Venkata Krishna Vamsi Gade iD, Jyoti Sharma iD, Sougata Maity iD, Tapesh Bhattacharyya iD, Srinivasa Gulladamane Yogeesha, Dharmendra Kumar Sah, Santam Chakraborty iD, Bhavana Rai iD, Sushmita Ghoshal iD

JCO Global Oncology · 2026-06 · 12 (6)

DOI: 10.1200/go-25-00765 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JCO Global Oncology, 2026-06. Verfasst von Venkata Krishna Vamsi Gade und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Christie NHS Foundation Trust, Manchester, UK. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, COVID-19, Time-to-Treatment. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE The COVID-19 pandemic caused major disruptions in cancer diagnosis and treatment in India. This retrospective two-center study evaluated delays in cervical cancer care during the pandemic and their impact on treatment outcomes. MATERIALS AND METHODS Records of newly diagnosed patients with cervical cancer registered between March 2020 and December 2021 were reviewed. Patients were considered in the delay group if they had: more than 3 months between symptom onset and diagnosis, over 6 weeks from diagnosis to treatment initiation, or over four consecutive days of radiotherapy interruption. Causes of delays, stage migration, and treatment impact were analyzed. Survival was assessed using the Kaplan-Meier method and compared with the log-rank test. RESULTS Of the 418 patients, 268 (64.1%) experienced delays. Diagnostic delay occurred in 220 (52.6%), treatment initiation delay in 126 (30.1%), and radiotherapy interruption in 84 (20%). Logistic issues accounted for most delays (54%), whereas COVID-19 infection caused 7.6%. Upward stage migration occurred in 22% of the delay group versus 11.3% without delays ( P = .004). Definitive radiotherapy with brachytherapy was the most common treatment (63.8%). The median follow-up was 37 months. The overall survival at 1, 2, and 3 years was 75%, 58%, and 52% in the delay group versus 92%, 87%, and 84% without delays ( P < .001). Progression-free survival at 1, 2, and 3 years was 65%, 54%, and 46% in the delay group versus 91%, 86%, and 79% without delays ( P < .001). Survival differences remained statistically significant on multivariable analysis. CONCLUSION Delays in cervical cancer care during the pandemic led to higher stage at diagnosis and poorer survival outcomes. These findings underscore the need for strategies to optimize resources and reduce delays in future health crises.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsCOVID-19Time-to-TreatmentHumansFemaleIndiaRetrospective StudiesTreatment DelayMiddle AgedSARS-CoV-2AdultPandemicsBrachytherapyAged

Autor:innen und Institutionen

  • The Christie NHS Foundation Trust, Manchester, UK.
  • Department of Radiation Oncology, AIIMS, Bathinda, India.
  • Department of Radiation Oncology, Tata Medical Centre, Kolkata, India.
  • Department of Radiotherapy and Oncology, PGIMER, Chandigarh, India.

ORCID-Profile: Venkata Krishna Vamsi Gade, Jyoti Sharma, Sougata Maity, Tapesh Bhattacharyya, Santam Chakraborty, Bhavana Rai, Sushmita Ghoshal

Zitieren

APA

Vamsi Gade, V. K., Sharma, J., Maity, S., Bhattacharyya, T., Gulladamane Yogeesha, S., Sah, D. K., Chakraborty, S., Rai, B., & Ghoshal, S. (2026). Real-World Data From India on Delays and Disruptions in Cervical Cancer Care Services During the COVID-19 Pandemic. JCO Global Oncology, 12(6). https://doi.org/10.1200/go-25-00765

Vancouver

Vamsi Gade VK, Sharma J, Maity S, Bhattacharyya T, Gulladamane Yogeesha S, Sah DK, et al. Real-World Data From India on Delays and Disruptions in Cervical Cancer Care Services During the COVID-19 Pandemic. JCO Global Oncology. 2026;12(6). doi:10.1200/go-25-00765

BibTeX
@article{VamsiGade2026,
  author = {Vamsi Gade, Venkata Krishna and Sharma, Jyoti and Maity, Sougata and Bhattacharyya, Tapesh and Gulladamane Yogeesha, Srinivasa and Sah, Dharmendra Kumar and Chakraborty, Santam and Rai, Bhavana and Ghoshal, Sushmita},
  title = {Real-World Data From India on Delays and Disruptions in Cervical Cancer Care Services During the COVID-19 Pandemic},
  journal = {JCO Global Oncology},
  year = {2026},
  volume = {12},
  number = {6},
  doi = {10.1200/go-25-00765}
}
Kostenlos starten →